echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Three types of imitation inhalants of Jiming Trust are accepted by CDE

    Three types of imitation inhalants of Jiming Trust are accepted by CDE

    • Last Update: 2022-01-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On December 17, Jimin Credential announced that its wholly-owned subsidiary, Jiyu Pharmaceutical Innovation Technology and Drug Research Institute, independently developed the first three types of generic inhalation preparations—levalbuterol hydrochloride aerosol inhalation solution, which has been approved by the National Drug Administration.


    Compared with ordinary salbutamol, the levosalbutamol hydrochloride aerosol inhalation solution removes the dextrorotate which is more selective for β1 receptors and brings side effects, and only retains the levosalbutamol which is more selective for β2 receptors


    In 2019, Wang Chen, an academician of the Chinese Academy of Engineering and an expert in respiratory and critical care medicine, published research results in The Lancet, clarifying the prevalence of adult asthma in China: the prevalence of asthma in people aged 20 and above in China is 4.


    Note: The original text has been deleted

    Reference materials:

    1.


    2.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.